Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Novartis reported $3.23B in EBIT for its fiscal quarter ending in March of 2023.

Ebit Change
Alcon AG ALC:SW USD 272M 248M
Almirall SA ALM:SM EUR 8.84M 1.47M
Amgen AMGN:US USD 2.1B 129M
Artemis Alpha ATS:LN GBP -16578000 10.12M
AstraZeneca AZN:LN USD 2.78B 943M
Bayer BAYN:GR EUR 3.4B 534M
Biogen BIIB:US USD 574.4M 304.3M
Bristol-Myers Squibb BMY:US USD 3B 686M
Eli Lilly LLY:US USD 1.6B 515.6M
Fresenius FRE:GR EUR 908M 425M
Fresenius Medical Care FME:GR EUR 301M 450.17M
Galapagos GLPG:NA EUR 21.97M 154.43M
Genmab GEN:DC DKK 437M 2.23B
Gilead Sciences GILD:US USD 1.71B 558M
GlaxoSmithKline GSK:LN GBP 1.92B 483M
Hikma Pharmaceutical HIK:LN USD 253M 3M
J&J JNJ:US USD 7.12B 826.8M
Lonza Group LONN:SW CHF 901M 203M
Merck & Co MRK:US USD 4.41B 1.14B
Novartis NOVN:VX USD 3.23B 123M
Novartis NVS:US USD 3.23B 123M
Orion ORNBV:FH EUR 55.5M 14.8M
Pfizer PFE:US USD 6.91B 1.1B
Philips PHIA:NA EUR 285M 263M
Recordati REC:IM EUR 175.35M 70.82M
Regeneron Pharmaceuticals REGN:US USD 1B 174M
Roche Holding ROG:VX CHF 8.49B 3.05B